EXPERIMENTAL AND CLINICAL TRANSPLANTATION, vol.10, no.3, pp.296-298, 2012 (Journal Indexed in SCI)
The mammalian target of rapamycin inhibitors is commonly preferred for solid organs for transplantation. Although these drugs have various adverse effects, sirolimus-related lymphedema has been rarely reported.